Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Advagene Biopharma Co., Ltd. (6709.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-15.86
P/B ratioShare price divided by book value per share.
3.99
P/S ratioMarket value divided by annual revenue.
0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-12.17
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-6.30%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
-33.48%
Return on assetsProfit as a percentage of total assets.
-20.63%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
44.32
Quick ratioThe same, excluding inventory.
44.19
Debt to equityTotal borrowings against shareholders’ equity.
0.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-1.51
Book value per shareShareholders’ equity divided by shares outstanding.
$6.00
Shares outstandingShares currently issued.
69,380,000
Market capitalisationShare price times shares outstanding.
$1.66B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
16
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
Advagene Biopharma Co., Ltd. (6709.TWO) trades on a price-to-earnings ratio of -15.86. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Advagene Biopharma Co., Ltd.'s return on equity?
Advagene Biopharma Co., Ltd. (6709.TWO) reports a return on equity of -33.48%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Advagene Biopharma Co., Ltd. carry?
Advagene Biopharma Co., Ltd. (6709.TWO) has a debt-to-equity ratio of 0.01, which compares total borrowings with shareholders' equity.